Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C F Shield

Showing results (61-70 of 87) with videos related to

Pageof 9
Sort By:
Transplantation|July 1, 1992
Use of indomethacin to minimize the adverse reactions associated with orthoclone OKT3 treatment of kidney allograft rejectionC F Shield, L Kahana, J Pirsch, et al.
Transplantation Proceedings|December 1, 1992
Influence of HLA and race on long-term cadaveric renal transplantationC F Bryan, M I Aeder, T S Helling, et al.
Transplant Immunology|September 1, 1995
The OKT3 Antibody Response Study: a multicentre study of human anti-mouse antibody (HAMA) production following OKT3 use in solid organ transplantationJ A Kimball, D J Norman, C F Shield, et al.
Transplantation Proceedings|April 1, 1993
OKT3 antibody response study: comparative testing of human antimouse antibodyJ A Kimball, D J Norman, C F Shield, et al.
Clinical Transplantation|June 11, 2003
Point-of-care testing in an organ procurement organization donor management settingK A Baier, L E Markham, S P Flaigle, et al.
Transplantation Proceedings|February 1, 1996
Allocation of kidneys to Afro-American patients is proportional to wait-list compositionC F Bryan, C F Shield, B A Warady, et al.
Transplantation Proceedings|February 1, 1995
OKT3 prophylaxis improves long-term renal graft survival in high-risk patients as compared to cyclosporine: combined results from the prospective, randomized Belgian and US studiesD Abramowicz, D J Norman, M Goldman, et al.
Transplantation Proceedings|February 1, 1993
OKT3 antibody response study (OARS): a multicenter comparative studyJ A Kimball, D J Norman, C F Shield, et al.
Transplantation Proceedings|December 1, 1992
Current experience with renal transplantation across the ABO blood group barrierC F Bryan, P W Nelson, M I Aeder, et al.
Transplantation Proceedings|February 1, 1993
Incidence and clinical impact of hepatitis C virus-positive donors in cadaveric transplantationM I Aeder, C F Shield, G E Tegtmeier, et al.
Pageof 9

Showing results (61-70 of 87) with videos related to

Sort By:
Pageof 9
Transplantation|July 1, 1992
Use of indomethacin to minimize the adverse reactions associated with orthoclone OKT3 treatment of kidney allograft rejectionC F Shield, L Kahana, J Pirsch, et al.
Transplantation Proceedings|December 1, 1992
Influence of HLA and race on long-term cadaveric renal transplantationC F Bryan, M I Aeder, T S Helling, et al.
Transplant Immunology|September 1, 1995
The OKT3 Antibody Response Study: a multicentre study of human anti-mouse antibody (HAMA) production following OKT3 use in solid organ transplantationJ A Kimball, D J Norman, C F Shield, et al.
Transplantation Proceedings|April 1, 1993
OKT3 antibody response study: comparative testing of human antimouse antibodyJ A Kimball, D J Norman, C F Shield, et al.
Clinical Transplantation|June 11, 2003
Point-of-care testing in an organ procurement organization donor management settingK A Baier, L E Markham, S P Flaigle, et al.
Transplantation Proceedings|February 1, 1996
Allocation of kidneys to Afro-American patients is proportional to wait-list compositionC F Bryan, C F Shield, B A Warady, et al.
Transplantation Proceedings|February 1, 1995
OKT3 prophylaxis improves long-term renal graft survival in high-risk patients as compared to cyclosporine: combined results from the prospective, randomized Belgian and US studiesD Abramowicz, D J Norman, M Goldman, et al.
Transplantation Proceedings|February 1, 1993
OKT3 antibody response study (OARS): a multicenter comparative studyJ A Kimball, D J Norman, C F Shield, et al.
Transplantation Proceedings|December 1, 1992
Current experience with renal transplantation across the ABO blood group barrierC F Bryan, P W Nelson, M I Aeder, et al.
Transplantation Proceedings|February 1, 1993
Incidence and clinical impact of hepatitis C virus-positive donors in cadaveric transplantationM I Aeder, C F Shield, G E Tegtmeier, et al.
Pageof 9